Brazil Breast Pump Market Report

Brazil Breast Pump Market Executive Summary

The Brazil Breast Pump Market is at around $73.5 Mn in 2023 and is projected to reach $139.6 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period.

A breast pump is a mechanical device that lactating women use to extract milk from their breasts. They are available in two forms; they can be manual devices powered by hand or foot movements or automatic devices powered by electricity. Breast pumps are available in a variety of styles to meet the demands of moms. Hand-operated manual pumps are lightweight and silent, making them ideal for sporadic usage. Electric pumps are often used on a regular basis because of their higher efficiency and ability to run on mains or batteries. There are several uses for breast pumps. Many parents use them to continue breastfeeding after they return to work. They express their milk at work, which is later bottle-fed to their child by a caregiver. A breast pump may be also used to address a range of challenges parents may encounter during breastfeeding, including difficulties latching, separation from an infant in intensive care, feeding an infant who cannot extract sufficient milk itself from the breast, to avoid passing medication through breast milk to the baby, or to relieve engorgement, which is a painful condition whereby the breasts are overfull.

The Brazil Breast Pump Market is driven by significant factors such as the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. However, high cost, lack of insurance coverage, and stigma and embarrassment restrict the growth and potential of the market.

The major players in the Brazil Breast Pump Market are Ardo, CA-MI, Lansinoh, Microlife, Nubeca, and Nuby, among others.

Market Dynamics

Market Growth Drivers

Improving healthcare infrastructure: With the enhancement of the healthcare system, maternal and infant health has gained significant attention, leading to a heightened demand for breast pumps. Improved healthcare facilities now provide superior lactation support, education, and awareness about the advantages of breastfeeding, prompting more mothers to choose breast pumps. Furthermore, the growth of healthcare infrastructure in developing areas ensures that breast pumps are more accessible and affordable, driving market expansion and enabling more mothers to conveniently breastfeed, even in difficult situations.

Growing consumer awareness: The rising awareness among consumers is a crucial factor propelling the growth of the Breast Pump Market. With more accessible information about breastfeeding benefits and breast pump convenience from healthcare providers, online platforms, and social media, more mothers are being encouraged to use breast pumps. Advocacy from health organizations and government programs promoting breastfeeding for infant health further raises this awareness. Additionally, the modern need for parenting flexibility and workplace support for breastfeeding mothers have increased breast pump adoption rates, thereby driving market expansion.

Rising disposable incomes: The Breast Pump Market is significantly propelled by rising disposable incomes, which enhance the capacity of households to invest in quality healthcare products. With more financial flexibility, families are increasingly able to purchase advanced breast pump models that provide superior convenience, efficiency, and comfort. This economic uptrend not only allows for greater affordability but also fosters a heightened awareness and prioritization of health and wellness. As a result, the demand for breastfeeding support products grows, motivating manufacturers to innovate and expand their product lines, thereby driving further market expansion.

Market Restraints

High Cost: The high cost of advanced breast pumps can act as a significant market growth restraint. Despite the benefits of features such as hands-free operation, advanced technology, and higher efficiency, the high prices prevent usage from budget-conscious consumers. This is especially relevant in rural regions where healthcare reimbursements for breastfeeding equipment are limited. As a result, many potential buyers are lost, constraining the market growth.

Lack of Insurance Coverage: In Brazil, where many healthcare expenses are out-of-pocket, the absence of insurance support for breast pumps limits their accessibility and affordability for a significant portion of the population. This financial barrier often deters prospective buyers from investing in these essential breastfeeding tools, particularly among lower-income families. Without broader insurance coverage, the market for breast pumps in Brazil struggles to reach its full potential.

Stigma and Embarrassment: The stigma and embarrassment associated with using breast pumps can act as a restraint on the breast pump market’s growth. Social and cultural perceptions about breastfeeding and breast pump use can deter some women from utilizing these devices, particularly in public or workplace settings. The use of breast pumps causes discomfort with the visibility of the pump, concerns about judgment, or lack of support from employers and society. These societal attitudes can hinder broader adoption and acceptance, potentially limiting market growth.

Regulatory Landscape and Reimbursement Scenario

The Agência Nacional de Vigilância Sanitária (ANVISA), often known as the National Health Surveillance Agency, is the Brazilian regulatory body in charge of approving and monitoring a variety of products, including food, cosmetics, tobacco, medications, health services, and medical devices. ANVISA was created in 1999 and is linked to the Ministry of Health. ANVISA aims to safeguard and advance public health by conducting health surveillance over goods and services, including procedures, components, and technology that may present health concerns.

Pharmaceutical laboratories and other businesses that are a part of the pharmaceutical production cycle must register their drugs and obtain licenses from ANVISA. The agency is also in charge of creating rules that apply to clinical trials in the areas of subject safety and drug Chemistry, Manufacturing, and Control (CMC). Additionally, ANVISA collaborates with the Chamber of Drug Market Regulation (CMED) and other ministry members to control pharmaceutical prices. Human clinical trials conducted ethically are overseen by an Ethics Committee (EC) affiliated with the Health Ministry. The agency inspects manufacturers, monitors drug quality, conducts post-marketing surveillance, performs pharmacovigilance activities, and controls drug marketing and promotion in collaboration with states and local governments. Furthermore, ANVISA, in collaboration with the National Industrial Property Institute (INPI), assesses patent requests pertaining to pharmaceutical items and procedures. After becoming an ICH member in November 2016, Brazil sought to facilitate regulatory approval by implementing the Common Technical Document (CTD) for the registration of medicines.

Brazil’s dual-structure healthcare reimbursement system serves both the public and private sectors. All Brazilian citizens and permanent residents are eligible for free at-the-point healthcare coverage through the Unified Health System (SUS). The government provides direct money to SUS facilities and patients do not have their own reimbursement procedure. However, due to financial limitations, SUS may have problems including lengthy wait periods and restricted access to cutting-edge therapies. A significant portion of the population is covered by private health insurance, which provides a greater choice of treatments and faster wait times than SUS. Private insurance firms pay medical providers according to prearranged contracts or schedules of fees. Methods of reimbursement may differ but usually include: Fee-for-Service (FFS) which provides payment according to the quantity of services rendered; Diagnosis Groups (DRGs) assign a predetermined cost for treating a certain illness; and in Managed Care Networks, the providers under contract offer discounted services.

Competitive Landscape

Key Players

Here are some of the major key players in the Brazil Breast Pump Market:

• Ardo
• CA-MI
• Lansinoh
• Microlife
• Nubeca
• Nuby
• Elvie
• Bistos
• Ameda
• Avent